Fullife Healthcare raises Rs 300 Cr from Elev8 Venture Partners
The investment marks Elev8’s first bet in the direct-to-consumer segment and its sixth from the current fund, signaling a broader push into consumer-focused platforms alongside its existing technology-led portfolio.
Fullife Healthcare, the parent company that sells wellness products like Fast&Up has raised Rs 300 crore in a Series D funding round led by Elev8 Venture Partners, as the company looks to expand its portfolio of nutrition and wellness brands and scale its international presence.
The investment marks Elev8’s first bet in the direct-to-consumer segment and its sixth from the current fund, signaling a broader push into consumer-focused platforms alongside its existing technology-led portfolio.
Fullife operates brands including Fast&Up and Chicnutrix, offering more than 100 products across hydration, sports nutrition, metabolic health and beauty supplements. The company said it is currently profitable.
The fresh capital will be used to expand these brands as well as NightOut, while also entering adjacent categories such as digestive health, sleep support and protein nutrition.
Founded in 2011, Fullife has built its business around nutrition products in formats such as tablets, powders and ready-to-drink solutions. The company is present in more than 40 countries and is now targeting deeper expansion in markets including the U.K., the Gulf region and the U.S.
The company said it plans to invest in strengthening distribution, expanding retail reach and increasing online penetration, alongside scaling manufacturing and product innovation.
For Elev8, the investment reflects growing investor interest in health and wellness, a category that has seen rising consumer spending driven by increased focus on fitness and preventive care.
The deal was advised by Avendus Capital.
The funding comes as a number of consumer health startups in India look to build global-facing brands, betting on demand for science-led nutrition and wellness products beyond traditional pharmaceuticals.
Elev8 has built a portfolio spanning fintech, consumer internet and enterprise-focused platforms, with a focus on companies that have already demonstrated product-market fit and are entering a scaling phase.
Among its key investments are IDfy, which provides digital verification and fraud detection services, and Smallcase, a platform that enables retail investors to buy curated portfolios of stocks.
In the consumer and services space, Elev8 has invested in Astrotalk, a digital marketplace for astrology services, and Porter, which operates in the intra-city logistics segment, catering to small businesses and enterprises.
The firm typically invests at the Series B and C stages, writing mid-sized growth cheques and positioning itself as a partner to companies preparing for larger late-stage rounds or public market listings.

